Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
  1. 2019
  2. Published
  3. Published

    Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

    Canet, L. M., Sánchez-Maldonado, J. M., Cáliz, R., Rodríguez-Ramos, A., Lupiañez, C. B., Canhão, H., Martínez-Bueno, M., Escudero, A., Segura-Catena, J., Sorensen, S. B., Hetland, M. L., Soto-Pino, M. J., Ferrer, M. A., García, A., Glintborg, B., Filipescu, I., Pérez-Pampin, E., González-Utrilla, A., Nevot, M. Á. L., Conesa-Zamora, P., den Broeder, A., De Vita, S., Jacobsen, S. E. H., Collantes-Estevez, E., Quartuccio, L., Canzian, F., Fonseca, J. E., Coenen, M. J. H., Andersen, V. & Sainz, J., Dec 2019, In : The pharmacogenomics journal. 19, 6, p. 582

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published
  5. Published
  6. Published

    Impact of red meat, processed meat and fibre intake on risk of late-onset chronic inflammatory diseases: prospective cohort study on lifestyle factors using the Danish 'Diet, Cancer and Health' cohort (PROCID-DCH): protocol

    Rasmussen, N. F., Rubin, K. H., Stougaard, M., Tjønneland, A., Stenager, E., Lund Hetland, M., Glintborg, B., Bygum, A. & Andersen, V., 30 Mar 2019, In : BMJ Open. 9, 3, p. e024555

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published
  8. Published

    Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden

    Grøn, K. L., Arkema, E. V., Glintborg, B., Mehnert, F., Østergaard, M., Dreyer, L., Nørgaard, M., Krogh, N. S., Askling, J., Hetland, M. L. & ARTIS Study Group, Mar 2019, In : Annals of the Rheumatic Diseases. 78, 3, p. 320-327 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    COMORBIDITIES IN >5000 PATIENTS WITH RHEUMATOID ARTHRITIS INITIATING TREATMENT WITH METHOTREXATE IN ROUTINE CARE: PREVALENCE AND IMPACT ON TREATMENT OUTCOMES. AN OBSERVATIONAL COHORT STUDY FROM DANBIO

    Glintborg, B., Krogh, N. S., Mehnert, F. & Hetland, M. L., 2019, In : Annals of the Rheumatic Diseases. 78, Suppl. 2, p. 339-340 2 p., THU0134.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  10. Published

    DANBIO, Dansk Reumatologisk Database, præsenterer sin fjortende årsrapport

    Hetland, M. L., Jensen, D. V., Adelsten, T., Agerbo, J., Dalgaard, E. B., Glintborg, B., Hansen, R. B., Hansen, M. S., Holland-Fischer, M., Matthiesen, M. Y., Pedersen, J. K., Schlemmer, A., Ziegler, C. & Svensson, E., 2019, In : Ugeskrift for Laeger. 21/10-2019, p. 1-5 5 p.

    Research output: Contribution to journalContribution to newspaper - Newspaper articleCommunication

  11. Published

    DIRECT COMPARISON OF CERTOLIZUMAB PEGOL, ABATACEPT AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN ROUTINE CARE. OBSERVATIONAL DATA FROM THE DANISH DANBIO REGISTRY ANALYZED LIKE A RANDOMIZED CLINICAL TRIAL

    Grøn, K. L., Glintborg, B., Nørgaard, M., Mehnert, F., Østergaard, M., Dreyer, L., Krogh, N. S., Bjørner, J. B. & Hetland, M. L., 2019, In : Annals of the Rheumatic Diseases. 78, Suppl. 2, p. 1391 1 p., SAT0595.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  12. Published

    Does a Mandatory Non- medical Switch from Originator to Biosimilar Etanercept Lead to Increase in Healthcare Use and Costs? A Danish Register- based Study of 1620 Patients with Infl ammatory Arthritis

    Glintborg, B., Ibsen, R., Bilbo, R. E. Q., Hetland, M. L. & Kjellberg, J., 2019, In : Arthritis & Rheumatology. 71, S10, 3 p., 0205.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  13. Published

    Does a mandatory non-medical switch from originator to biosimilar etanercept lead to increase in healthcare use and costs? A Danish register-based study of patients with inflammatory arthritis

    Glintborg, B., Ibsen, R., Bilbo, R. E. Q., Lund Hetland, M. & Kjellberg, J., 2019, In : RMD Open. 5, 2, p. e001016

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    EFFECTIVENESS OF TNF INHIBITORS VS. NON-TNF INHIBITORS (ABATACEPT, TOCILIZUMAB AND RITUXIMAB) AFTER FAILURE OF NON-TNFI BIOLOGIC DMARD IN RHEUMATOID ARTHRITIS – COLLABORATION BETWEEN FIVE NATIONAL REGISTERS

    Chatzidionysiou, K., Hetland, M. L., Frisell, T., Giuseppe, D. D., Hellgren, K., Glintborg, B., Nordström, D., Aaltonen, K., Trokovic, N., Kristianslund, E., Kvien, T. K., Provan, S. A., Gudbjørnsson, B., Gröndal, G., Dreyer, L., Kristensen, L. E., Jørgensen, T. S., Jacobsson, L. T. H. & Askling, J., 2019, In : Annals of the Rheumatic Diseases. 78, Suppl. 2, p. 703-704 2 p., FRI0082.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  15. Published

    Hepatobiliary Events in >5000 Patients with Infl ammatory Arthritis Treated with Biosimilar or Originator Etanercept in Routine Care, Results from the Danish Nationwide DANBIO Registry

    Glintborg, B., Georgiadis, S., Nørgaard, M., Mehnert, F., Grøn, K. L., Krogh, N. S. & Hetland, M. L., 2019, In : Arthritis & Rheumatology. 71, S10, 3 p., 2406.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  16. Published

    IDENTICAL TWO-YEAR TREATMENT RETENTION OF ORIGINATOR AND BIOSIMILAR INFLIXIMAB. RESULTS OF A NORDIC COLLABORATION INCLUDING 1319 PATIENTS WITH SPONDYLOARTHRITIS

    Lindström, U., Glintborg, B., Guiseppe, D. D., Askling, J., Nordström, D., Provan, S. A., Gudbjornsson, B., Hetland, M. L., Aaltonen, K., Krogh, N. S., Geirsson, A. J. & Jacobsson, L. T. H., 2019, In : Annals of the Rheumatic Diseases. 78, Suppl. 2, p. 871 1 p., FRI0377.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  17. Published

    OVERALL INFECTION RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ABATACEPT, RITUXIMAB AND TOCILIZUMAB. AN OBSERVATIONAL COHORT STUDY

    Grøn, K. L., Glintborg, B., Mehnert, F., Østergaard, M., Dreyer, L., Nørgaard, M., Krogh, N. S. & Hetland, M. L., 2019, In : Annals of the Rheumatic Diseases. 78, Suppl. 2, p. 630 1 p., THU0667.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  18. Published

    Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

    Canet, L. M., Sánchez-Maldonado, J. M., Cáliz, R., Ramos, A. R., Lupiañez, C. B., Canhão, H., Martínez-Bueno, M., Escudero, A., Segura-Catena, J., Sorensen, S. B., Hetland, M. L., Soto-Pino, M. J., Ferrer, M. A., García, A., Glintborg, B., Filipescu, I., Pérez-Pampin, E., González-Utrilla, A., Nevot, M. Á. L., Conesa-Zamora, P., Broeder, A. D., De Vita, S., Jacobsen, S. E. H., Collantes-Estevez, E., Quartuccio, L., Canzian, F., Fonseca, J. E., Coenen, M. J. H., Andersen, V. & Sainz, J., 2019, In : The pharmacogenomics journal. 19, 1, p. 83-96

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    RISK OF HOSPITALIZED INFECTION IN PATIENTS WITH CHRONIC INFLAMMATORY ARTHRITIS TREATED WITH BIOLOGICAL DRUGS – A MATCHED COHORT STUDY

    Krabbe, S., Grøn, K. L., Glintborg, B., Mehnert, F., Jarbøl, D. E., Østergaard, M. & Hetland, M. L., 2019, In : Annals of the Rheumatic Diseases. 78, Suppl. 2, p. 214 1 p., OP0266.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  20. Published

    SECULAR CHANGES IN PSORIATIC ARTHRITIS PATIENTS STARTING FIRST COURSE OF BIOLOGIC THERAPIES – INFLAMMATORY HALLMARKS OF LESSER PROMINENCE: A NORDIC POPULATIONBASED COHORT STUDY

    Hansen, R. L., Jørgensen, T. S., Dreyer, L., Gudbjornsson, B., Askling, J., Hetland, M. L., Glintborg, B., Giuseppe, D. D., Jacobsson, L. T. H., Kvien, T., Nordström, D., Aaltonen, K., Provan, S. A., Kristianslund, E., Wallman, J. K., Love, T. J. & Kristensen, L. E., 2019, In : Annals of the Rheumatic Diseases. 78, Suppl. 2, p. 1263-1264 2 p., SAT0365.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  21. Published

    SIMILAR ONE-YEAR TREATMENT RETENTION OF ORIGINATOR AND BIOSIMILAR ETANERCEPT. RESULTS OF A NORDIC COLLABORATION INCLUDING 1015 PATIENTS WITH SPONDYLOARTHRITIS

    Glintborg, B., Lindström, U., Giuseppe, D. D., Askling, J., Nordström, D., Provan, S. A., Gudbjornsson, B., Hetland, M. L., Aaltonen, K., Geirsson, A. J., Krogh, N. S. & Jacobsson, L. T. H., 2019, In : Annals of the Rheumatic Diseases. 78, Suppl. 2, p. 196-197 2 p., OP0236.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  22. Published

    To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry

    Glintborg, B., Loft, A. G., Omerovic, E., Hendricks, O., Linauskas, A., Espesen, J., Danebod, K., Jensen, D. V., Nordin, H., Dalgaard, E. B., Chrysidis, S., Kristensen, S., Raun, J. L., Lindegaard, H., Manilo, N., Jakobsen, S. H., Hansen, I. M. J., Dalsgaard Pedersen, D., Sørensen, I. J., Andersen, L. S., Grydehøj, J., Mehnert, F., Krogh, N. S. & Hetland, M. L., 2019, In : Annals of the Rheumatic Diseases. 78, 2, p. 192-200 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis

    Lindström, U., Glintborg, B., Di Giuseppe, D., Nordström, D., Aarrestad Provan, S., Gudbjornsson, B., Askling, J., Lund Hetland, M., Aaltonen, K., Krogh, N. S., Geirsson, A. J. & Jacobsson, L. T. H., 2019, In : RMD Open. 5, 2, p. e001079

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. 2018
  25. Published

    Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological registries

    Glintborg, B., Lindström, U., Aaltonen, K., Kristianslund, E. K., Gudbjornsson, B., Chatzidionysiou, K., Askling, J., Nordström, D., Hetland, M. L., Di Giuseppe, D., Dreyer, L., Kristensen, L. E., Jørgensen, T. S., Eklund, K., Grondal, G., Ernestam, S., Joensuu, J., Törmänen, M., Skydsgaard, H., Hagfors, J., Kvien, T. K., Lie, E., Fagerli, K., Geirsson, A. J., Jonsson, H., Provan, S. A., Krogh, N. S. & Jacobsson, L., Nov 2018, In : Scandinavian Journal of Rheumatology. 47, 6, p. 465-474 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Genetically determined high activities of the TNF-alpha, IL23/IL17, and NFkB pathways were associated with increased risk of ankylosing spondylitis

    Sode, J., Bank, S., Vogel, U., Andersen, P. S., Sørensen, S. B., Bojesen, A. B., Andersen, M. R., Brandslund, I., Dessau, R. B., Hoffmann, H. J., Glintborg, B., Hetland, M. L., Locht, H., Heegaard, N. H. & Andersen, V., 12 Sep 2018, In : B M C Medical Genetics. 19, 1, p. 165-180 16 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published
  28. Published

    Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

    Glintborg, B., Kringelbach, T., Bolstad, N., Warren, D. J., Eng, G., Sørensen, I. J., Loft, A. G., Hendricks, O., Hansen, I., Linauskas, A., Nordin, H., Kristensen, S., Lindegaard, H., Jensen, D. V., Goll, G. L., Høgdall, E., Gehin, J., Enevold, C., Nielsen, C. H., Krogh, N. S., Johansen, J. S. & Hetland, M. L., Sep 2018, In : Scandinavian Journal of Rheumatology. 47, 5, p. 418-421 4 p.

    Research output: Contribution to journalLetterResearchpeer-review

  29. Published
  30. Published

    Correction: Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example

    Chatzidionysiou, K., Hetland, M. L., Frisell, T., Giuseppe, D. D., Hellgren, K., Glintborg, B., Nordström, D., Aaltonen, K., Törmänen, M. R. K., Kristianslund, E. K., Kvien, T. K., Provan, S. A., Gudbjörnsson, B., Dreyer, L., Kristensen, L. E., Jørgensen, T. S., Jacobsson, L. & Askling, J., 2018

    Research output: Other contributionResearch

  31. Published
  32. Published
  33. Published
  34. Published

    Gender differences in biologic treatment outcomes – A study of 1750 patients with psoriatic arthritis using Danish health care registers

    Højgaard, P., Ballegaard, C., Cordtz, R. L., Zobbe, K., Clausen, M., Kristensen, L. E., Glintborg, B. & Dreyer, L., 2018, In : Annals of the Rheumatic Diseases. 77, Suppl. 2, p. 376 1 p., THU0316.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  35. Published

    Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis

    Loft, N. D., Skov, L., Rasmussen, M. K., Gniadecki, R., Dam, T. N., Brandslund, I., Hoffmann, H. J., Andersen, M. R., Dessau, R. B., Bergmann, A. C., Andersen, N. M., Abildtoft, M. K., Andersen, P. S., Hetland, M. L., Glintborg, B., Bank, S., Vogel, U. & Andersen, V., 2018, In : PLoS One. 13, 2, p. e0192010

    Research output: Contribution to journalJournal articleResearchpeer-review

  36. Published

    One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator. An observational Danbio study

    Glintborg, B., Sørensen, I. J., Omerovic, E., Mehnert, F., Manilo, N., Danebod, K., Jensen, D. V., Nordin, H., Loft, A. G., Hendricks, O., Chrysidis, S., Andersen, B. L., Raun, J. L., Lindegaard, H., Espesen, J., Jakobsen, S. H., Hansen, I. M. J., Dalsgaard, E. B., Pedersen, D. D., Kristensen, S., Linauskas, A., Andersen, L. S., Grydehøj, J., Krogh, N. S. & Hetland, M. L., 2018, In : Annals of the Rheumatic Diseases. 77, Suppl. 2, p. 595-6 2 p., FRI0103.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  37. Published

    One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: An observational DANBIO study

    Glintborg, B., Sørensen, I. J., Omerovic, E., Mehnert, F., Manilo, N., Danebod, K., Jensen, D. V., Nordin, H., Hendricks, O., Loft, A. G., Chrysidis, S., Andersen, B. L., Raun, J. L., Lindegaard, H., Espesen, J., Jakobsen, S. H., Hansen, I. J., Dalgaard, E. B., Pedersen, D. D., Kristensen, S., Linauskas, A., Andersen, L. S., Grydehøj, J., Krogh, N. S. & Hetland, M. L., 2018, In : Scandinavian Journal of Rheumatology, Supplement. 47, Suppl. 129, p. 56-7 2 p., PP66.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  38. Published

    One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2,061 patients with inflammatory arthritis followed in the Danbio registry

    Glintborg, B., Sørensen, I. J., Omerovic, E., Mehnert, F., Manilo, N., Danebod, K., Jensen, D. V., Nordin, H., Loft, A. G., Hendricks, O., Chrysidis, S., Andersen, B. L., Raun, J. L., Lindegaard, H., Espesen, J., Jakobsen, S. H., Hansen, I. M. J., Dalsgaard, E. B., Pedersen, D. D., Kristensen, S., Linauskas, A., Andersen, L. S., Grydehøj, J., Krogh, N. & Hetland, M. L., 2018, In : Annals of the Rheumatic Diseases. 77, Suppl. 2, p. 313-4 2 p., THU0189.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  39. Published

    One-year treatment retention after a nationwide nonmedical switch from originator to biosimilar etanercept in 2061 patients with inflammatory arthritis followed in the DANBIO registry

    Glintborg, B., Sørensen, I. J., Omerovic, E., Mehnert, F., Manilo, N., Danebod, K., Jensen, D. V., Nordin, H., Hendricks, O., Loft, A. G., Chrysidis, S., Andersen, B. L., Raun, J. L., Lindegaard, H., Espesen, J., Jakobsen, S. H., Hansen, I. J., Dalgaard, E. B., Pedersen, D. D., Kristensen, S., Linauskas, A., Andersen, L. S., Grydehøj, J., Krogh, N. S. & Hetland, M. L., 2018, In : Scandinavian Journal of Rheumatology, Supplement. 47, Suppl. 129, p. 57-8 2 p., PP67.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  40. Published

    Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example

    Chatzidionysiou, K., Hetland, M. L., Frisell, T., Di Giuseppe, D., Hellgren, K., Glintborg, B., Nordström, D., Aaltonen, K., Törmänen, M. R., Klami Kristianslund, E., Kvien, T. K., Provan, S. A., Björn Guðbjörnsson, B., Dreyer, L., Kristensen, L. E., Jørgensen, T. S., Jacobsson, L. & Askling, J., 2018, In : RMD Open. 4, 1, p. e000655

    Research output: Contribution to journalReviewResearchpeer-review

  41. Published

    Pain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis: Results of a Danish prospective, exploratory cohort study

    Højgaard, P., Ellegaard, K., Nielsen, S. M., Christensen, R., Guldberg-Møller, J., Ballegaard, C., Dreyer, L., Mease, P., De Wit, M., Skov, L., Glintborg, B., Bliddal, H., Bartels, E. M., Amris, K. & Kristensen, L. E., 2018, In : Annals of the Rheumatic Diseases. 77, Suppl. 2, p. 1016 1 p., SAT0303.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  42. Published

    Polymorphisms in phase i-metabolising enzyme and hormone receptor genes influence the response to anti-TNF therapy

    Canet, L. M., Sánchez-Maldonado, J. M., Rodriguez-Ramos, A., Lupiañez, C. B., Canhão, H., Martinez-Bueno, M., Escudero, A., Segura-Catena, J., Sørensen, S. B., Hetland, M. L., Soto-pino, M. J., Ferrer, M. A., Garcia, A., Glintborg, B., Filipescu, I., Pérez-Pampin, E., Gonzalez-Utrilla, A., Lopez-Nevot, M. A., Conesa-Zamora, P., den Broeder, A. A., da Vita, S., Hove Jacobsen, S. E., Collantes, E., Quartuccio, L., Fonseca, J. E., Coenen, M. J., Andersen, V., Caliz-Caliz, R. & Sainz, J., 2018, In : Annals of the Rheumatic Diseases. 77, Suppl. 2, p. 234-5 2 p., THU0010.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  43. Published

    Rheumatoid Arthritis Patients Treated with Abatacept, Rituximab and Tocilizumab in Denmark and Sweden: Risk of Serious Infections

    Grøn, K. L., Arkema, E. V., Glintborg, B., Mehnert, F., Østergaard, M., Dreyer, L., Nørgaard, M., Krogh, N. S., Askling, J. & Hetland, M. L., 2018, In : Arthritis & Rheumatology. 70, S9, 2 p., 227.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  44. Published

    Risk of serious infections in rheumatoid arthritis patients treated with abatacept, rituximab and tocilizumab in Denmark and Sweden

    Grøn, K. L., Arkema, E. V., Glintborg, B., Mehnert, F., Østergaard, M., Dreyer, L., Nørgaard, M., Krogh, N. S., Askling, J. & Hetland, M. L., 2018, In : Annals of the Rheumatic Diseases. 77, Suppl. 2, p. 208 1 p., OP0324.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  45. 2017
  46. Published

    A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

    Glintborg, B., Sørensen, I. J., Loft, A. G., Lindegaard, H., Linauskas, A., Hendricks, O., Hansen, I. M. J., Jensen, D. V., Manilo, N., Espesen, J., Klarlund, M., Grydehøj, J., Dieperink, S. S., Kristensen, S., Olsen, J. S., Nordin, H., Chrysidis, S., Dalsgaard Pedersen, D., Sørensen, M. V., Andersen, L. S., Grøn, K. L., Krogh, N. S., Pedersen, L., Hetland, M. L. & all departments of rheumatology in Denmark, Aug 2017, In : Annals of the Rheumatic Diseases. 76, 8, p. 1426-1431 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  47. Published

    Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry

    Glintborg, B., Sørensen, I. J., Østergaard, M., Dreyer, L., Mohamoud, A. A., Krogh, N. S., Hendricks, O., Andersen, L. S., Raun, J. L., Kowalski, M. R., Danielsen, L., Pelck, R., Nordin, H., Pedersen, J. K., Kraus, D. G., Christensen, S. R., Hansen, I. M., Esbesen, J., Schlemmer, A., Loft, A. G., Al Chaer, N., Salomonsen, L. & Hetland, M. L., Jan 2017, In : Journal of Rheumatology. 44, 1, p. 59-69 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  48. Published

    Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers

    Hellgren, K., Dreyer, L., Arkema, E. V., Glintborg, B., Jacobsson, L. T. H., Kristensen, L-E., Feltelius, N., Hetland, M. L., Askling, J. & ARTIS Study Group, For the DANBIO Study Group, Jan 2017, In : Annals of the Rheumatic Diseases. 76, 1, p. 105-111 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  49. Published

    Baseline Characteristics and Rates of Hospitalized Infections in Patients with Rheumatoid Arthritis Treated with Non-TNF Inhibitors in Denmark and Sweden

    Grøn, K. L., Arkema, E. V., Glintborg, B., Askling, J. & Hetland, M. L., 2017, In : Arthritis & Rheumatology. 69, S10, 134.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  50. Published

    Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry

    Glintborg, B., Sørensen, I. J., Loft, A. G., Esbesen, J., Lindegaard, H., Jensen, D. V., Danebod, K., Dieperink, S. S., Hendricks, O., Hansen, I. M. J., Linauskas, A., Kristensen, S., Andersen, L. S., Hossein, M., Nordin, H., Andersen, B. L., Chrysidis, S., Raun, J. L., Manillo, N., Grydehøj, J., Dalgaard, E. B., Pedersen, D. D., Krogh, N. S. & Hetland, M. L., 2017, In : Annals of the Rheumatic Diseases. 76, Suppl 2, p. 553-554 2 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  51. Published
  52. Published

    First Line Biological Treatment in Ankylosing Spondylitis, Prescription Rates, Baseline Demographics and Disease Activity. a Collaboration between Biological Registers in the Five Nordic Counties

    Glintborg, B., Lindström, U., Aaltonen, K., Kristianslund, E. K., Gudbjornsson, B., Chatzidionysiou, K., Askling, J., Nordström, D., Hetland, M. L., Guiseppe, D. D., Dreyer, L., Jørgensen, T. S., Kristensen, L. E., Eklund, K., Grondal, G., Ernestam, S., Joensuu, J., Kvien, T. K., Lie, E., Fagerli, K. M., Geirsson, A. J., Jonsson, H. & Jacobsson, L. T. H., 2017, In : Arthritis & Rheumatology. 69, S10, 1541.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  53. Published

    Mandatory choice of first bDMARD in Denmark – an opportunity to study real-life effectiveness? Results from the Danbio registry

    Grøn, K. L., Glintborg, B., Nørgaard, M., Mehnert, F., Østergaard, M., Dreyer, L., Krogh, N. S. & Hetland, M. L., 2017, In : Annals of the Rheumatic Diseases. 76, Suppl 2, p. 451 1 p., THU0649.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

Previous 1 2 3 Next

ID: 32278327